SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes
Diabetes Care · 01.01.2024 · 47 (1) · e4-e5
DOI: 10.2337/dc23-1903 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diabetes Care, online erschienen am 14.11.2023. Verfasst von Annabelle G Hayes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Ketoacidosis, Ketosis, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia.
- Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.
- School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
- Department of Heart and Lung Transplantation, St Vincent's Hospital, Sydney, Australia.
- Victor Chang Cardiac Research Institute, Sydney, Australia.
ORCID-Profile: Annabelle G Hayes, Lisa M Raven
Zitieren
APA
Hayes, A. G., Raven, L. M., Viardot, A., Kotlyar, E., & Greenfield, J. R. (2024). SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes. Diabetes Care, 47(1), e4-e5. https://doi.org/10.2337/dc23-1903
Vancouver
Hayes AG, Raven LM, Viardot A, Kotlyar E, Greenfield JR. SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes. Diabetes Care. 2024;47(1):e4-e5. doi:10.2337/dc23-1903
BibTeX
@article{Hayes2024,
author = {Hayes, Annabelle G and Raven, Lisa M and Viardot, Alexander and Kotlyar, Eugene and Greenfield, Jerry R},
title = {SGLT2 Inhibitor–Induced Ketoacidosis in a Patient Without Diabetes},
journal = {Diabetes Care},
year = {2024},
volume = {47},
number = {1},
pages = {e4--e5},
doi = {10.2337/dc23-1903}
}
EUVIMED